TY - JOUR
T1 - AB093. Pixel-wise classification of glioma using deep learning for accurate tumour mapping on magnetic resonance imaging
AU - Aftab, Kiran
AU - Asif, Salma
AU - Rahman, Ansar
AU - Wara, Ummul
AU - Raees, Faryal
AU - Shahid, Ahmad Raza
AU - Farrukh, Amna
AU - Fareed, Ceemal
AU - Nasir, Manal
AU - Tariq, Rabeet
AU - Sameer, Muhammad
AU - Angez, Meher
AU - Saleem, Zeba
AU - Naeem, Komal
AU - Mughal, Muhammad Nouman
AU - Mubarak, Fatima
AU - Enam, Syed Ather
PY - 2024/8/1
Y1 - 2024/8/1
N2 - BACKGROUND: Central nervous system (CNS) tumours, especially glioma, are a complex disease and many challenges are encountered in their treatment. Artificial intelligence (AI) has made a colossal impact in many walks of life at a low cost. However, this avenue still needs to be explored in healthcare settings, demanding investment of resources towards growth in this area. We aim to develop machine learning (ML) algorithms to facilitate the accurate diagnosis and precise mapping of the brain tumour. METHODS: We queried the data from 2019 to 2022 and brain magnetic resonance imaging (MRI) of glioma patients were extracted. Images that had both T1-contrast and T2-fluid-attenuated inversion recovery (T2-FLAIR) volume sequences available were included. MRI images were annotated by a team supervised by a neuroradiologist. The extracted MRIs thus obtained were then fed to the preprocessing pipeline to extract brains using SynthStrip. They were further fed to the deep learning-based semantic segmentation pipelines using UNet-based architecture with convolutional neural network (CNN) at its backbone. Subsequently, the algorithm was tested to assess the efficacy in the pixel-wise diagnosis of tumours. RESULTS: In total, 69 samples of low-grade glioma (LGG) were used out of which 62 were used for fine-tuning a pre-trained model trained on brain tumor segmentation (BraTS) 2020 and 7 were used for testing. For the evaluation of the model, the Dice coefficient was used as the metric. The average Dice coefficient on the 7 test samples was 0.94. CONCLUSIONS: With the advent of technology, AI continues to modify our lifestyles. It is critical to adapt this technology in healthcare with the aim of improving the provision of patient care. We present our preliminary data for the use of ML algorithms in the diagnosis and segmentation of glioma. The promising result with comparable accuracy highlights the importance of early adaptation of this nascent technology.
AB - BACKGROUND: Central nervous system (CNS) tumours, especially glioma, are a complex disease and many challenges are encountered in their treatment. Artificial intelligence (AI) has made a colossal impact in many walks of life at a low cost. However, this avenue still needs to be explored in healthcare settings, demanding investment of resources towards growth in this area. We aim to develop machine learning (ML) algorithms to facilitate the accurate diagnosis and precise mapping of the brain tumour. METHODS: We queried the data from 2019 to 2022 and brain magnetic resonance imaging (MRI) of glioma patients were extracted. Images that had both T1-contrast and T2-fluid-attenuated inversion recovery (T2-FLAIR) volume sequences available were included. MRI images were annotated by a team supervised by a neuroradiologist. The extracted MRIs thus obtained were then fed to the preprocessing pipeline to extract brains using SynthStrip. They were further fed to the deep learning-based semantic segmentation pipelines using UNet-based architecture with convolutional neural network (CNN) at its backbone. Subsequently, the algorithm was tested to assess the efficacy in the pixel-wise diagnosis of tumours. RESULTS: In total, 69 samples of low-grade glioma (LGG) were used out of which 62 were used for fine-tuning a pre-trained model trained on brain tumor segmentation (BraTS) 2020 and 7 were used for testing. For the evaluation of the model, the Dice coefficient was used as the metric. The average Dice coefficient on the 7 test samples was 0.94. CONCLUSIONS: With the advent of technology, AI continues to modify our lifestyles. It is critical to adapt this technology in healthcare with the aim of improving the provision of patient care. We present our preliminary data for the use of ML algorithms in the diagnosis and segmentation of glioma. The promising result with comparable accuracy highlights the importance of early adaptation of this nascent technology.
KW - brain tumor segmentation (BraTS)
KW - convolutional neural network (CNN)
KW - Glioma
KW - magnetic resonance imaging (MRI)
KW - UNet
UR - http://www.scopus.com/inward/record.url?scp=85204418954&partnerID=8YFLogxK
U2 - 10.21037/cco-24-ab093
DO - 10.21037/cco-24-ab093
M3 - Article
C2 - 39295411
AN - SCOPUS:85204418954
SN - 2304-3865
VL - 13
SP - AB093
JO - Chinese Clinical Oncology
JF - Chinese Clinical Oncology
ER -